The acquired von Willebrand syndrome (AvWS) is a rare bleeding disorder with laboratory
findings similar to those of inherited von Willebrand disease. However, unlike the inherited …

Acquired haemophilia is a potentially life‐threatening bleeding disorder caused by the
development of autoantibodies against coagulation factors, most commonly against factor …

ABSTRACT Objectives: Acquired hemophilia A (AHA) is a rare, but potentially life-
threatening, bleeding disorder caused by an autoantibody against factor VIII that interferes …

Acquired haemophilia A (AHA) is a rare but often severe bleeding disorder caused by
autoantibodies against coagulation factor VIII (FVIII). AHA occurs more frequently in the …

Acquired hemophilia A (AHA) should be suspected in patients with a new onset of bleeding
and an isolated prolongation of activated partial thromboplastin time. About 10% of patients …

Autoantibodies affecting the activity or accelerating the clearance of clotting factors
(acquired inhibitors) can develop in patients with autoimmune or malignant disorders, but …

Acquired hemophilia A (AHA) is a rare severe autoimmune bleeding disorder with significant
morbidity and mortality. Although critical for disease control, there is no consensus for the …

Background Acquired haemophilia A (AHA) is a rare bleeding disorder due to
autoantibodies to coagulation factor VIII that may be secondary to autoimmune diseases …

Acquired hemophilia A (AHA) is a rare acquired bleeding disorder caused by autoantibodies
against autologous factor VIII (FVIII). It is a disease that most commonly affects the elderly …

Acquired haemophilia A (AHA) is a rare bleeding disorder caused by inhibitory
autoantibodies against coagulation factor VIII (FVIII). AHA is a disease that most commonly …